Cue Biopharma (CUE) SEC Filings & 10K Form

$1.74
-0.18 (-9.38%)
(As of 05/10/2024 ET)

Recent Cue Biopharma SEC Filings

DateFilerForm TypeView
04/26/2024
2:43 PM
Cue Biopharma (Filer)
Form ARS
04/26/2024
2:46 PM
Cue Biopharma (Filer)
Form DEFA14A
03/28/2024
3:29 PM
Cue Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
5:40 PM
Bleichroeder LP (Filed by)
Cue Biopharma (Subject)
Form SC 13G
02/07/2024
4:09 PM
BlackRock Inc. (Filed by)
Cue Biopharma (Subject)
Form SC 13G
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Cue Biopharma (Subject)
Form SC 13G
01/04/2024
3:00 PM
Cue Biopharma (Issuer)
Morich Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:01 PM
Cue Biopharma (Issuer)
Verheyen Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
DRISCOLL FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
Kiener Peter A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:02 PM
Cue Biopharma (Issuer)
Garzone Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:01 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2023
11:25 AM
Cue Biopharma (Issuer)
Suri Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
11:27 AM
Cue Biopharma (Issuer)
Sandercock Colin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
11:28 AM
Cue Biopharma (Issuer)
PASSERI DANIEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
11:31 AM
Cue Biopharma (Issuer)
Millar Kerri-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
11:33 AM
Cue Biopharma (Issuer)
Levisetti Matteo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
3:31 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2023
11:15 PM
Cue Biopharma (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CUE) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners